Open AccessMP41-12 AVELUMAB FIRST-LINE MAINTENANCE PLUS BEST SUPPORTIVE CARE VS BEST SUPPORTIVE CARE ALONE FOR ADVANCED UROTHELIAL CARCINOMA: ANALYSIS OF TIME TO END OF NEXT-LINE THERAPY IN JAVELIN BLADDER 100
Author(s) -
Petros Grivas,
Se Hoon Park,
Éric Voog,
Evgeny Kopyltsov,
Howard Gurney,
David Queiroz Borges Muniz,
Fréderic Rolland,
Anne Birgitte Als,
Begoña P. Valderrama,
Jing Wang,
Nuno Costa,
Rachelle Laliberte,
Alessandra di Pietro,
Thomas Powles,
Joaquim Bellmunt
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000002062.12
Subject(s) - medicine , avelumab , urothelial carcinoma , javelin , hospice care , bladder cancer , palliative care , cancer , nursing , immunotherapy , pembrolizumab , mechanical engineering , engineering , throwing